- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 266.05M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $4M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $380M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $598M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.03B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.12B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.07B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.16B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.1B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.18B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 266.4M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $10M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$265M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.36B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.33B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.11 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.11 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $101M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $20M |
| Net Income | Q1 2025 · Mar 31, 2024 | $29M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $43M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $153M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $535M |
| Revenue | Q1 2025 · Mar 31, 2024 | $688M |